gallopamil and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

gallopamil has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kübler, W; Neumann, FJ; Ott, I; Rauch, B; Richardt, G; Tillmanns, H; Zimmermann, R1
Alabaster, VA; Cheeseman, HE; Cooper, K; deSouza, RN; Keir, RF; Parry, MJ1

Trials

1 trial(s) available for gallopamil and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Effect of gallopamil on neutrophil function: experimental and clinical studies.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 7

    Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Gallopamil; Humans; In Vitro Techniques; Neutrophils; Platelet Activating Factor; Superoxides; Tetradecanoylphorbol Acetate

1992

Other Studies

1 other study(ies) available for gallopamil and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.
    Journal of lipid mediators and cell signalling, 1994, Volume: 10, Issue:3

    Topics: Administration, Oral; Animals; Aorta; Azepines; Blood Platelets; Brain; Calcium Channels, L-Type; Capillary Permeability; Cattle; Dihydropyridines; Diltiazem; Gallopamil; Guinea Pigs; Hypotension; Imidazoles; In Vitro Techniques; Kinetics; Male; Membranes; Mice; Mice, Inbred Strains; Muscle Contraction; Muscle Proteins; Nitrendipine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Potassium Chloride; Rabbits; Rats; Rats, Sprague-Dawley; Skin; Triazoles; Tritium

1994